"Memorial Sloan Kettering Basking Ridge provides the same outstanding cancer care as our New York City locations, in a state-of-the-art outpatient facility that is convenient for residents of New Jersey. For general information, call Memorial Sloan Kettering at 212-639-2000, 24 hours a day, seven days a week. To make an appointment, call us at 833-494-2758, Monday through Friday between 8:00 AM and 6:00 PM ET."

During the past decade, Memorial Sloan Kettering Basking Ridge conducted 447 clinical trials. In the 10-year time frame, 447 clinical trials started and 115 clinical trials were completed, i.e. on average, 25.7% percent of trials that started reached the finish line to date. In the past 5 years, 207 clinical trials started and 76 clinical trials were completed. i.e. 36.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Sloan Kettering Basking Ridge" #1 sponsor was "Memorial Sloan Kettering Cancer Center" with 459 trials, followed by "National Cancer Institute (NCI)" with 53 trials sponsored, "NRG Oncology" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored and "Pfizer" with 16 trials sponsored. Other sponsors include 52 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Sloan Kettering Basking Ridge" #1 collaborator was "National Cancer Institute (NCI)" with 65 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "Genentech, Inc." with 21 trials as a collaborator, "Merck Sharp & Dohme LLC" with 17 trials as a collaborator and "Weill Medical College of Cornell University" with 16 trials as a collaborator. Other collaborators include 554 different institutions and companies that were collaborators in the rest 286 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Sloan Kettering Basking Ridge" are "Breast Cancer" (57 trials), "Prostate Cancer" (26 trials), "Lung Cancer" (25 trials), "Multiple Myeloma" (23 trials) and "Head and Neck Cancer" (21 trials). Many other conditions were trialed in "Memorial Sloan Kettering Basking Ridge" in a lesser frequency.

Most popular intervention types in "Memorial Sloan Kettering Basking Ridge" are "Drug" (413 trials), "Other" (143 trials), "Radiation" (120 trials), "Procedure" (94 trials) and "Behavioral" (58 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (34 trials), "Pembrolizumab" (29 trials), "Nivolumab" (28 trials), "Carboplatin" (27 trials) and "Cisplatin" (27 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Sloan Kettering Basking Ridge" are 479 trials for "All" genders, 103 trials for "Female" genders and 31 trials for "Male" genders.

Currently, there are NaN active trials in "Memorial Sloan Kettering Basking Ridge". undefined are not yet recruiting, 223 are recruiting, 212 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 151 completed trials in Memorial Sloan Kettering Basking Ridge, 2 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Sloan Kettering Basking Ridge, 104 "Phase 1" clinical trials were conducted, 311 "Phase 2" clinical trials and 98 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 53 trials that are defined as “Not Applicable".